Wells Fargo analyst Sam Reid initiates coverage on Toll Brothers (NYSE:TOL) with a Overweight rating and announces Price Target of $80.
Wells Fargo announces Toll Brothers (NYSE:TOL) Price Target of $80 Read Post »
Bernstein analyst Bob Brackett downgrades EOG Resources (NYSE:EOG) from Outperform to Market Perform and lowers the price target from $155 to $146.
Bernstein lowers EOG Resources (NYSE:EOG) price target from $155 to $146 Read Post »
Bernstein analyst Bob Brackett downgrades Pioneer Natural Resources (NYSE:PXD) from Outperform to Market Perform and lowers the price target from $273 to $246.
Bernstein lowers Pioneer Natural Resources (NYSE:PXD) price target from $273 to $246 Read Post »
Oppenheimer analyst Chris Kotowski maintains Citigroup (NYSE:C) with a Outperform and raises the price target from $81 to $82.
Oppenheimer raises Citigroup (NYSE:C) price target from $81 to $82 Read Post »
JPMorgan analyst Michael Glick upgrades Nucor (NYSE:NUE) from Underweight to Neutral and announces $151 price target.
JPMorgan announces Nucor (NYSE:NUE) $151 price target Read Post »
JPMorgan analyst Tami Zakaria maintains Caterpillar (NYSE:CAT) with a Overweight and raises the price target from $315 to $320.
JPMorgan raises Caterpillar (NYSE:CAT) price target from $315 to $320 Read Post »
Moderna on Monday reiterated its expected COVID-19 vaccine sales of $6 billion to $8 billion for 2023 amid the uncertainty of vaccination rates in the US. The biotechnology company said it anticipates being in the bottom half of the range if the US market for COVID-19 jabs registers 50 million administered doses in 2023, and projects to be within the top half for 100 million administered doses. Moderna will provide an update after evaluating full vaccination trends through October.
Moderna Affirms FY23 Forecast of Up to $8 Billion in COVID-19 Vaccine Sales Read Post »
JPMorgan analyst Ann Duignan downgrades Cummins (NYSE:CMI) from Neutral to Underweight and lowers the price target from $270 to $255.
JPMorgan lowers Cummins (NYSE:CMI) price target from $270 to $255 Read Post »
JPMorgan analyst Andrea Teixeira maintains Coca-Cola (NYSE:KO) with a Overweight and lowers the price target from $71 to $59.
JPMorgan lowers Coca-Cola (NYSE:KO) price target from $71 to $59 Read Post »
Piper Sandler analyst Alexander Potter maintains Tesla (NASDAQ:TSLA) with a Overweight and lowers the price target from $300 to $290.
Piper Sandler lowers Tesla (NASDAQ:TSLA) price target from $300 to $290 Read Post »
Piper Sandler analyst Jessica Tassan maintains UnitedHealth Group (NYSE:UNH) with a Overweight and raises the price target from $580 to $584.
Piper Sandler raises UnitedHealth Group (NYSE:UNH) price target from $580 to $584 Read Post »
Disney is aiming to break even on its direct-to-consumer business in the next year, UBS analysts say in a research note. The company’s challenges in linear, exacerbated in the recently-completed quarter by the Charter blackout, are also expected to continue, but the analysts anticipate Disney management will look to emphasize efforts such as price hikes, ad-supported streaming and cost discipline related to Disney+, which will push the streaming service toward profitability. The company reports 4Q results early next month.
Disney Expected To Emphasize FY24 Breakeven for Disney+ Read Post »